Virginia Surgery Associates offers a comprehensive Pancreatic Cancer Screening Program to:
- Reduce risk and implement prevention strategies
- Identify and offer early detection of pancreatic cancer in high risk patients
- Offer early treatment options once diagnosed thus improving survival from the disease
Our Program Includes:
- A multidisciplinary team who works together to assess an individual’s risk of developing pancreatic cancer
- Regular evaluations, genetic counseling, and for patients who are deemed to be high risk; annual monitoring byradiologic studies such as an MRI or Ultrasound (EUS) of the pancreas
Pancreatic Cancer Facts
- Pancreatic cancer accounts for about 3% of all cancers and 7% of all cancer deaths in the U.S.
- The average lifetime risk for pancreatic cancer is 1.5% (or 1 in 63) among men and women
- By the end of 2018, 55,440 people in the U.S. were diagnosed with pancreatic cancer and 44,300 will die of the disease
- It is the fourth leading cause of cancer deaths
- Early detections and multi-modality treatment improve survival
Who is at risk?
- NCCN guidelines suggest genetic testing for any pancreatic cancer patient as of 2018
- Certain genetic syndromes and a family history of pancreatic cancer
- Hereditary syndromes include: Breast and Ovarian Cancer Syndrome, Hereditary Colon Cancer (HNPCC), Familial Atypical Multiple Mole Melanoma, Peutz-Jeghers Syndrome, BRCA 1 and 2 patients
- Two or more first degree relatives or three or more any relative with a pancreatic cancer diagnosis
For more information or to schedule an appointment with our Pancreatic Cancer Screening Program, please call (703) 359-8640.